Abstract
Toll-like receptor (TLR) signaling is essential for intestinal tumorigenesis in Apcmin/+ mice, but the mechanisms by which Apc enhances tumor growth are unknown. Here we show that microflora-MyD88-ERK signaling in intestinal epithelial cells (IECs) promotes tumorigenesis by increasing the stability of the c-Myc oncoprotein. Activation of ERK (extracellular signal–related kinase) phosphorylates c-Myc, preventing its ubiquitination and subsequent proteasomal degradation. Accordingly, Apcmin/+/Myd88−/− mice have lower phospho-ERK (p-ERK) levels and fewer and smaller IEC tumors than Apcmin/+ mice. MyD88 (myeloid differentiation primary response gene 88)-independent activation of ERK by epidermal growth factor (EGF) increased p-ERK and c-Myc and restored the multiple intestinal neoplasia (Min) phenotype in Apcmin/+/Myd88−/− mice. Administration of an ERK inhibitor suppressed intestinal tumorigenesis in EGF-treated Apcmin/+/Myd88−/− and Apcmin/+ mice and increased their survival. Our data reveal a new facet of oncogene-environment interaction, in which microflora-induced TLR activation regulates oncogene expression and related IEC tumor growth in a susceptible host.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
206,07 € per year
only 17,17 € per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout






Similar content being viewed by others
References
Michelsen, K.S. & Arditi, M. Toll-like receptors and innate immunity in gut homeostasis and pathology. Curr. Opin. Hematol. 14, 48–54 (2007).
Sanderson, I.R. & Walker, W.A. TLRs in the Gut I. The role of TLRs/Nods in intestinal development and homeostasis. Am. J. Physiol. Gastrointest. Liver Physiol. 292, G6–G10 (2007).
de Visser, K.E., Eichten, A. & Coussens, L.M. Paradoxical roles of the immune system during cancer development. Nat. Rev. Cancer 6, 24–37 (2006).
Karin, M. Nuclear factor-κB in cancer development and progression. Nature 441, 431–436 (2006).
Lin, W.W. & Karin, M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J. Clin. Invest. 117, 1175–1183 (2007).
Rakoff-Nahoum, S. & Medzhitov, R. Regulation of spontaneous intestinal tumorigenesis through the adaptor protein Myd88. Science 317, 124–127 (2007).
Oshima, M. et al. Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc. Natl. Acad. Sci. USA 92, 4482–4486 (1995).
Moser, A.R., Pitot, H.C. & Dove, W.F. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247, 322–324 (1990).
Weinstein, I.B. Cancer. Addiction to oncogenes—the Achilles heal of cancer. Science 297, 63–64 (2002).
Hurlin, P.J. & Huang, J. The MAX-interacting transcription factor network. Semin. Cancer Biol. 16, 265–274 (2006).
Wilkins, J.A. & Sansom, O.J. C-Myc is a critical mediator of the phenotypes of Apc loss in the intestine. Cancer Res. 68, 4963–4966 (2008).
Sansom, O.J. et al. Myc deletion rescues Apc deficiency in the small intestine. Nature 446, 676–679 (2007).
Yekkala, K. & Baudino, T.A. Inhibition of intestinal polyposis with reduced angiogenesis in Apcmin/+ mice due to decreases in c-Myc expression. Mol. Cancer Res. 5, 1296–1303 (2007).
Ignatenko, N.A. et al. Role of c-Myc in intestinal tumorigenesis of the Apcmin/+mouse. Cancer Biol. Ther. 5, 1658–1664 (2006).
Beutler, B. et al. Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. Annu. Rev. Immunol. 24, 353–389 (2006).
Boulares, A.H. et al. Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells. J. Biol. Chem. 274, 22932–22940 (1999).
Kelsall, B.L. & Rescigno, M. Mucosal dendritic cells in immunity and inflammation. Nat. Immunol. 5, 1091–1095 (2004).
Cario, E. et al. Commensal-associated molecular patterns induce selective toll-like receptor-trafficking from apical membrane to cytoplasmic compartments in polarized intestinal epithelium. Am. J. Pathol. 160, 165–173 (2002).
Lee, J. et al. Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat. Cell Biol. 8, 1327–1336 (2006).
Cho, H.J. et al. IFN-alpha beta promote priming of antigen-specific CD8+ and CD4+ T lymphocytes by immunostimulatory DNA-based vaccines. J. Immunol. 168, 4907–4913 (2002).
Apte, R.N. et al. The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions. Cancer Metastasis Rev. 25, 387–408 (2006).
Pedersen, G., Andresen, L., Matthiessen, M.W., Rask-Madsen, J. & Brynskov, J. Expression of Toll-like receptor 9 and response to bacterial CpG oligodeoxynucleotides in human intestinal epithelium. Clin. Exp. Immunol. 141, 298–306 (2005).
Sears, R. et al. Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev. 14, 2501–2514 (2000).
Sears, R.C. The life cycle of C-myc: from synthesis to degradation. Cell Cycle 3, 1133–1137 (2004).
Vervoorts, J., Luscher-Firzlaff, J. & Luscher, B. The ins and outs of MYC regulation by posttranslational mechanisms. J. Biol. Chem. 281, 34725–34729 (2006).
Chang, W.C. et al. Sulindac sulfone is most effective in modulating beta-catenin-mediated transcription in cells with mutant APC. Ann. NY Acad. Sci. 1059, 41–55 (2005).
Barrett, S.D. et al. The discovery of the benzhydroxamate MEK inhibitors CI-1040 and PD 0325901. Bioorg. Med. Chem. Lett. 18, 6501–6504 (2008).
Seo, T.C., Spallholz, J.E., Yun, H.K. & Kim, S.W. Selenium-enriched garlic and cabbage as a dietary selenium source for broilers. J. Med. Food 11, 687–692 (2008).
Coussens, L.M. & Werb, Z. Inflammation and cancer. Nature 420, 860–867 (2002).
Shacter, E. & Weitzman, S.A. Chronic inflammation and cancer. Oncology 16, 217–226, 229; discussion 230–232 (2002).
Fox, J.G. & Wang, T.C. Inflammation, atrophy, and gastric cancer. J. Clin. Invest. 117, 60–69 (2007).
Pikarsky, E. et al. NF-κB functions as a tumour promoter in inflammation-associated cancer. Nature 431, 461–466 (2004).
He, T.C. et al. Identification of c-MYC as a target of the APC pathway. Science 281, 1509–1512 (1998).
Dang, C.V. et al. The c-Myc target gene network. Semin. Cancer Biol. 16, 253–264 (2006).
Hann, S.R. Role of post-translational modifications in regulating c-Myc proteolysis, transcriptional activity and biological function. Semin. Cancer Biol. 16, 288–302 (2006).
Gregory, M.A. & Hann, S.R. c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells. Mol. Cell. Biol. 20, 2423–2435 (2000).
Dakour, J., Li, H., Chen, H. & Morrish, D.W. EGF promotes development of a differentiated trophoblast phenotype having c-myc and junB proto-oncogene activation. Placenta 20, 119–126 (1999).
Wickenden, J.A. et al. Colorectal cancer cells with the BRAF(V600E) mutation are addicted to the ERK1/2 pathway for growth factor-independent survival and repression of BIM. Oncogene 27, 7150–7161 (2008).
Sansom, O.J. et al. Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration. Genes Dev. 18, 1385–1390 (2004).
Dove, W.F. et al. Intestinal neoplasia in the ApcMin mouse: independence from the microbial and natural killer (beige locus) status. Cancer Res. 57, 812–814 (1997).
Acknowledgements
The authors thank P. Charos for animal breeding and S. Shenouda for tissue processing. This work was supported by US National Institutes of Health grants AI068685, CA133702, DK35108 and DK080506.
Author information
Authors and Affiliations
Contributions
E.R. designed the study; S.H.L. and J.L. performed the signaling experiments; C.S., L.-L.H., S.H. and G.S.S. performed the in vivo studies; M.C. generated the bone marrow chimeras; J.B., J.L. and J.G.-N. performed immunohistochemistry and flow cytometry; S.H.L., M.C., N.V., J.L. and E.R. analyzed the data; and S.H.L., J.L. and E.R. wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–4 (PDF 1241 kb)
Rights and permissions
About this article
Cite this article
Lee, S., Hu, LL., Gonzalez-Navajas, J. et al. ERK activation drives intestinal tumorigenesis in Apcmin/+ mice. Nat Med 16, 665–670 (2010). https://doi.org/10.1038/nm.2143
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.2143